Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells

Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in... Article history: The high hygroscopicity of gentamicin (G) as raw material hampers the production of respirable parti- Received 17 November 2011 cles during aerosol generation and prevents its direct use as powder for inhalation in patients suffering Received in revised form 12 January 2012 from cystic fibrosis (CF). Therefore, this research aimed to design a new dry powder formulation of G Accepted 13 January 2012 studying dispersibility properties of an aminoacid, l-leucine (leu), and appropriate process conditions. Available online 23 January 2012 Spray-dried powders were characterized as to water uptake, particle size distribution, morphology and stability, in correlation with process parameters. Aerodynamic properties were analyzed both by Single Keywords: Stage Glass Impinger and Andersen Cascade Impactor. Moreover, the potential cytotoxicity on bronchial Cystic fibrosis epithelial cells bearing a CFTR F508/F508 mutant genotype (CuFi1) were tested. Results indicated that Gentamicin sulfate leu may improve the aerosol performance of G-dried powders. The maximum fine particle fraction (FPF) l-leucine of about 58.3% was obtained when water/isopropyl alcohol 7:3 system and 15–20% (w/w) of leu were Spray drying Dry powder inhaler used, compared to a FPF value of 13.4% for neat G-dried powders. The enhancement of aerosol efficiency CF airway epithelial cells was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Pharmaceutics Elsevier

Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells

Loading next page...
 
/lp/elsevier/dry-powder-inhalers-of-gentamicin-and-leucine-formulation-parameters-7C6Xwdcz6q
Publisher
Elsevier
Copyright
Copyright © 2012 Elsevier B.V.
ISSN
0378-5173
D.O.I.
10.1016/j.ijpharm.2012.01.026
Publisher site
See Article on Publisher Site

Abstract

Article history: The high hygroscopicity of gentamicin (G) as raw material hampers the production of respirable parti- Received 17 November 2011 cles during aerosol generation and prevents its direct use as powder for inhalation in patients suffering Received in revised form 12 January 2012 from cystic fibrosis (CF). Therefore, this research aimed to design a new dry powder formulation of G Accepted 13 January 2012 studying dispersibility properties of an aminoacid, l-leucine (leu), and appropriate process conditions. Available online 23 January 2012 Spray-dried powders were characterized as to water uptake, particle size distribution, morphology and stability, in correlation with process parameters. Aerodynamic properties were analyzed both by Single Keywords: Stage Glass Impinger and Andersen Cascade Impactor. Moreover, the potential cytotoxicity on bronchial Cystic fibrosis epithelial cells bearing a CFTR F508/F508 mutant genotype (CuFi1) were tested. Results indicated that Gentamicin sulfate leu may improve the aerosol performance of G-dried powders. The maximum fine particle fraction (FPF) l-leucine of about 58.3% was obtained when water/isopropyl alcohol 7:3 system and 15–20% (w/w) of leu were Spray drying Dry powder inhaler used, compared to a FPF value of 13.4% for neat G-dried powders. The enhancement of aerosol efficiency CF airway epithelial cells was

Journal

International Journal of PharmaceuticsElsevier

Published: Apr 15, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off